Atherosclerosis and endothelial dysfunction in patients with ankylosing spondylitis

被引：0
|
作者：
V. F. Azevedo
R. Pecoits-Filho
机构：
[1] Federal University of Paraná,Head of Spondylarthropathies Service
[2] Pontificia Universidade Catolica do Parana,Graduate Program in Health Sciences
来源：
Rheumatology International | 2010年 / 30卷
关键词：
Spondylarthropathies; Ankylosing Spondylitis; Inflammation; Biomarkers; Cardiovascular disease; Atherosclerosis; Endothelial activation; Endothelial dysfunction; Arterial stiffness;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Ankylosing spondylitis (AS) is a systemic inflammatory rheumatic disease characterized primarily by axial joint involvement, sacroiliitis and various extra-articular manifestations. High cardiovascular mortality in AS has led many researchers to investigate possible risk factors involved with cardiovascular disease in these patients. This review summarizes published data concerning endothelial dysfunction and atherosclerosis in patients with AS. The author discusses current limitations and problems related to a better assessment of these two possible changes in AS.
引用
收藏
页码：1411 / 1416
页数：5
相关论文
共 50 条
  • [41] COGNITIVE DYSFUNCTION IN PATIENTS WITH ANKYLOSING SPONDYLITIS: ASSOCIATION WITH NEUROPATHIC PAIN
    Kedyk, Ivan
    Stanislavchuk, Mykola
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023, 29 : S100 - S101
  • [42] Increased prevalence of subclinical coronary atherosclerosis in young patients with ankylosing spondylitis
    Ozdowska, Patrycja
    Wardziak, Lukasz
    Kruk, Mariusz
    Kepka, Cezary
    Kowalik, Ilona
    Szwed, Hanna
    Gluszko, Piotr
    Rupinski, Robert
    Kwiatkowska, Brygida
    Sikorska-Siudek, Katarzyna
    Dabrowski, Rafal
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2018, 128 (7-8): : 455 - 461
  • [43] Endothelial dysfunction is independent of inflammation and altered CCR7 T cell expression in patients with ankylosing spondylitis
    Sulicka, J.
    Surdacki, A.
    Korkosz, M.
    Mikolajczyk, T.
    Strach, M.
    Klimek, E.
    Guzik, T.
    Grodzicki, T.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (05) : 844 - 849
  • [44] MYOCARDIAL DYSFUNCTION IN ANKYLOSING-SPONDYLITIS
    GOULD, BA
    TURNER, J
    KEELING, DH
    HICKLING, P
    MARSHALL, AJ
    BRITISH HEART JOURNAL, 1988, 59 (01): : 129 - 129
  • [45] MYOCARDIAL DYSFUNCTION IN ANKYLOSING-SPONDYLITIS
    GOULD, BA
    TURNER, J
    KEELING, DH
    HICKLING, P
    MARSHALL, AJ
    ANNALS OF THE RHEUMATIC DISEASES, 1992, 51 (02) : 227 - 232
  • [46] Subclinical atherosclerosis in ankylosing spondylitis: is there a role for inflammation?
    Mattar Valente, Renato Leandro
    Valente, Jamil Mattar
    Werner de Castro, Glaucio Ricardo
    Zimmermann, Adriana Fontes
    de Magalhaes Souza Fialho, Sonia Cristina
    Pereira, Ivelnio Alves
    REVISTA BRASILEIRA DE REUMATOLOGIA, 2013, 53 (05) : 377 - 381
  • [47] The LDL/HDL ratio and atherosclerosis in ankylosing spondylitis
    Kucuk, A.
    Uslu, A. Ugur
    Icli, A.
    Cure, E.
    Arslan, S.
    Turkmen, K.
    Toker, A.
    Kayrak, M.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2017, 76 (01): : 58 - 63
  • [48] Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor-α blockade
    Syngle, Ashit
    Vohra, Kanchan
    Sharma, Anjali
    Kaur, L.
    CLINICAL RHEUMATOLOGY, 2010, 29 (07) : 763 - 770
  • [49] Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor-α blockade
    Ashit Syngle
    Kanchan Vohra
    Anjali Sharma
    L. Kaur
    Clinical Rheumatology, 2010, 29 : 763 - 770
  • [50] INHIBITION OF INTERLEUKIN 17 REDUCES MYOCARDIAL DYSFUNCTION IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Lapshina, S. A.
    Feiskhanova, L. I.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : 1236 - 1236
12345